Recalls / Class I
Class ID-1269-2020
Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.
Product
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
- Affected lot / code info
- Lot #02-27-2020:04@11, Exp. August 25, 2020.
Why it was recalled
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Recalling firm
- Firm
- MasterPharm LLC
- Notification channel
- Telephone
- Type
- Voluntary: Firm initiated
- Address
- 11502 Liberty Ave Fl 2, N/A, South Richmond Hill, New York 11419-1902
Distribution
- Quantity
- 7260 capsules
- Distribution pattern
- Nationwide in the U.S.
Timeline
- Recall initiated
- 2020-04-14
- FDA classified
- 2020-05-19
- Posted by FDA
- 2020-05-20
- Terminated
- 2023-09-07
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1269-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.